2023 Conference Archive: Speakers

Irene Nunes
VP, Head of Regulatory Affairs, Flatiron Health, Chair of the ExecutiveBoard GetReal Institute

Catherine Cohet
Pharmacoepidemiology Senior Specialist,Data Analytics and MethodsTask Force,European MedicinesAgency(EMA)

Wija Oortwijn
PhD, Senior researcher, Radboud university medical center/HTAi President

Rick Grobbee
Professor of Clinical Epidemiology,University Medical Center Utrecht(UMCU)

Bettina Ryll
Founder, Melanoma Patient Network Europe (MPNE)

Virginia Acha
Global Regulatory Policy, MSD

Andrew Roddam
Chief Executive Officer,Our Future Health UK

Gracy Crane
Executive Director Integrated Solutions, Evidera

Nigel Hughes
Scientific Director, Observational Health Data Analytics/Epidemiology,
Johnson & Johnson &EHDEN Project Lead

Mira Zuidgeest
Epidemiologistand Associate Professor,University Medical CenterUtrecht(UMCU)

Shahid Hanif
Managing Director, GetReal Institute

Darren Toh
Principal Investigator | Sentinel Operations Center, Harvard Medical School & Harvard Pilgrim Health Care Institute

Peter Mol
Principal Clinical Assessor CBG-MEB (Dutch Medicines Evaluation Board),
Professor of drug regulatory science, University Medical Center Groningen; Member SAWP

Sebastian Garcia Marti
Coordinator of Health Technology Assessment (HTA) and Economic Evaluation, IECS(Argentina)

Churn-Shiouh Gau
Adjunct Professor, School of Pharmacy, National Taiwan University

Donna Rivera
Associate Director of Pharmacoepidemiology | RWD & RWE at FDAOncology Center of Excellence

Inka Heikkinen
Director, Global Regulatory Policy, EMEA,MSD

Wim G. Goettsch
Professor HTA of Pharmaceuticals, WHO Collaborating CentreforPharmaceutical Policy and Regulation; Division of Pharmacoepidemiology and ClinicalPharmacology, Utrecht University

Mark McClellan
MD, PhD, Robert J. Margolis Professor of Business, Medicine, and Policy, and founding Director of the Duke-Margolis Center for Health Policy at DukeUniversity